India Pharmas Join Pfizer In Trying Ways To Share Lipitor Generics
This article was originally published in PharmAsia News
Executive Summary
India has become a testing ground of sorts as large pharma companies try every business arrangement they can to make up for patent expirations on blockbuster drugs